Cargando…

Efficacy of black cohosh (Cimicifuga racemosa L.) in treating early symptoms of menopause: a randomized clinical trial

BACKGROUND: This study aims to evaluate the efficacy of Black cohosh (Cimicifuga racemosa L.) in treating early menopausal symptoms. METHODS: This randomized, double-blind, placebo-controlled clinical trial was conducted on 84 early post-menopausal participants with Greene climacteric scale (GCS) sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammad-Alizadeh-Charandabi, Sakineh, Shahnazi, Mahnaz, Nahaee, Jila, Bayatipayan, Somaei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029542/
https://www.ncbi.nlm.nih.gov/pubmed/24499633
http://dx.doi.org/10.1186/1749-8546-8-20
_version_ 1782317227132846080
author Mohammad-Alizadeh-Charandabi, Sakineh
Shahnazi, Mahnaz
Nahaee, Jila
Bayatipayan, Somaei
author_facet Mohammad-Alizadeh-Charandabi, Sakineh
Shahnazi, Mahnaz
Nahaee, Jila
Bayatipayan, Somaei
author_sort Mohammad-Alizadeh-Charandabi, Sakineh
collection PubMed
description BACKGROUND: This study aims to evaluate the efficacy of Black cohosh (Cimicifuga racemosa L.) in treating early menopausal symptoms. METHODS: This randomized, double-blind, placebo-controlled clinical trial was conducted on 84 early post-menopausal participants with Greene climacteric scale (GCS) scores of 15 to 42, who were referred to two public health care centers in Tehran, Iran, in 2011–2012. The participants were randomly allocated into treatment (6.5 mg of dried extract of Black cohosh roots daily) and control (placebo) groups with a ratio of 1:1. The participants took one tablet per day for 8 weeks. The GCS scores were recorded at baseline, and after 4 and 8 weeks of treatment. Data analysis was carried out using a general linear model with repeated measures with SPSS software. The level of significance was set at P < 0.05. RESULTS: There was no loss to follow-up during the 8 weeks of treatment. The GCS total score (primary outcome) in the treatment group was significantly lower than that in the control group at both week 4 [adjusted mean difference: -7.8 (95% confidence interval: -11.1 to -4.4)] and week 8 [-12.9 (-16.2 to -9.3)]. The treatment group showed significantly more improvement than the control group in all GCS subscale scores (vasomotor, psychiatric, physical, and sexual symptoms; secondary outcomes). The differences between the treatment and control groups at week 8 were significantly higher (P < 0.001) than those at week 4 in terms of the total scores and the vasomotor and psychiatric subscale scores. No side effects were reported. CONCLUSIONS: Black cohosh reduced the GCS total score and all GCS subscale scores (vasomotor, psychiatric, physical, and sexual symptoms) during 4 and 8 weeks of treatment. CLINICAL TRIAL REGISTRATION: This study was approved (Code 9061) by the Ethics Committee of Tabriz University of Medical Sciences and registered at the Iranian Registry of Clinical Trials with IRCT201107186709N4 on 15 January 2012.
format Online
Article
Text
id pubmed-4029542
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40295422014-05-22 Efficacy of black cohosh (Cimicifuga racemosa L.) in treating early symptoms of menopause: a randomized clinical trial Mohammad-Alizadeh-Charandabi, Sakineh Shahnazi, Mahnaz Nahaee, Jila Bayatipayan, Somaei Chin Med Research BACKGROUND: This study aims to evaluate the efficacy of Black cohosh (Cimicifuga racemosa L.) in treating early menopausal symptoms. METHODS: This randomized, double-blind, placebo-controlled clinical trial was conducted on 84 early post-menopausal participants with Greene climacteric scale (GCS) scores of 15 to 42, who were referred to two public health care centers in Tehran, Iran, in 2011–2012. The participants were randomly allocated into treatment (6.5 mg of dried extract of Black cohosh roots daily) and control (placebo) groups with a ratio of 1:1. The participants took one tablet per day for 8 weeks. The GCS scores were recorded at baseline, and after 4 and 8 weeks of treatment. Data analysis was carried out using a general linear model with repeated measures with SPSS software. The level of significance was set at P < 0.05. RESULTS: There was no loss to follow-up during the 8 weeks of treatment. The GCS total score (primary outcome) in the treatment group was significantly lower than that in the control group at both week 4 [adjusted mean difference: -7.8 (95% confidence interval: -11.1 to -4.4)] and week 8 [-12.9 (-16.2 to -9.3)]. The treatment group showed significantly more improvement than the control group in all GCS subscale scores (vasomotor, psychiatric, physical, and sexual symptoms; secondary outcomes). The differences between the treatment and control groups at week 8 were significantly higher (P < 0.001) than those at week 4 in terms of the total scores and the vasomotor and psychiatric subscale scores. No side effects were reported. CONCLUSIONS: Black cohosh reduced the GCS total score and all GCS subscale scores (vasomotor, psychiatric, physical, and sexual symptoms) during 4 and 8 weeks of treatment. CLINICAL TRIAL REGISTRATION: This study was approved (Code 9061) by the Ethics Committee of Tabriz University of Medical Sciences and registered at the Iranian Registry of Clinical Trials with IRCT201107186709N4 on 15 January 2012. BioMed Central 2013-11-01 /pmc/articles/PMC4029542/ /pubmed/24499633 http://dx.doi.org/10.1186/1749-8546-8-20 Text en Copyright © 2013 Mohammad-Alizadeh-Charandabi et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Mohammad-Alizadeh-Charandabi, Sakineh
Shahnazi, Mahnaz
Nahaee, Jila
Bayatipayan, Somaei
Efficacy of black cohosh (Cimicifuga racemosa L.) in treating early symptoms of menopause: a randomized clinical trial
title Efficacy of black cohosh (Cimicifuga racemosa L.) in treating early symptoms of menopause: a randomized clinical trial
title_full Efficacy of black cohosh (Cimicifuga racemosa L.) in treating early symptoms of menopause: a randomized clinical trial
title_fullStr Efficacy of black cohosh (Cimicifuga racemosa L.) in treating early symptoms of menopause: a randomized clinical trial
title_full_unstemmed Efficacy of black cohosh (Cimicifuga racemosa L.) in treating early symptoms of menopause: a randomized clinical trial
title_short Efficacy of black cohosh (Cimicifuga racemosa L.) in treating early symptoms of menopause: a randomized clinical trial
title_sort efficacy of black cohosh (cimicifuga racemosa l.) in treating early symptoms of menopause: a randomized clinical trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029542/
https://www.ncbi.nlm.nih.gov/pubmed/24499633
http://dx.doi.org/10.1186/1749-8546-8-20
work_keys_str_mv AT mohammadalizadehcharandabisakineh efficacyofblackcohoshcimicifugaracemosalintreatingearlysymptomsofmenopausearandomizedclinicaltrial
AT shahnazimahnaz efficacyofblackcohoshcimicifugaracemosalintreatingearlysymptomsofmenopausearandomizedclinicaltrial
AT nahaeejila efficacyofblackcohoshcimicifugaracemosalintreatingearlysymptomsofmenopausearandomizedclinicaltrial
AT bayatipayansomaei efficacyofblackcohoshcimicifugaracemosalintreatingearlysymptomsofmenopausearandomizedclinicaltrial